Faculty Appointments
Patient Care Settings
Cancer, Radiation Oncology
Biography
Every patient and every cancer is unique. While each patient should be treated individually, all patients need compassionate care.
I chose this field because I find that using cutting-edge technology to treat and help cancer patients is very rewarding. My areas of expertise include thoracic and central nervous system tumors and treatment of oligometastases with radiation.
I am a native Rochesterian who attended McQuaid Jesuit High School and trained at the University of Rochester School of Medicine and Dentistry.
Conditions I Treat:
- Benign and malignant brain tumors
- Benign and malignant spine tumors
- Thoracic tumors
- Lung cancer
- Oligometastases
Professional Background
Dr. Milano is an Assistant Professor of Radiation Oncology at the University of Rochester School of Medicine and Dentistry.
Dr. Milano's practice focuses on the care of patients with primary brain tumors, brain metastases, spine tumors, benign intracranial tumors (such as pituitary tumors, acoustic neuromas and meningiomas) and trigeminal neuralgia. Dr. Milano also treats patients with lung cancer and other thoracic tumors, head and neck cancer and metastatic cancer. He is involved in clinical research in all of these areas.
Dr. Milano is a board certified Radiation Oncologist. His undergraduate training was at the University of Notre Dame. His medical school, graduate school and internship training were at the University of Rochester. He received his residency training in Radiation Oncology at the University of Chicago. In 2005, he returned to Rochester to become a faculty member at University of Rochester's internationally recognized Department of Radiation Oncology. Dr. Milano has clinical expertise in stereotactic radiosurgery (SRS), stereotactic body (including spine) radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image guided radiation therapy (IGRT) and tomotherapy.
Credentials
Specialties
- Radiation Oncology - American Board of Radiology
Education
2000
MD | University of Rochester Medical Center
Post-doctoral Training & Residency
07/01/2001 - 06/30/2005
Residency in Radiation Oncology at University of Chicago, Pritzker School of Medicine
07/01/2000 - 06/30/2001
Internship in Internal Medicine at University of Rochester Medical Center
Awards
2019
Outstanding Reviewer in 2018 from Int J Radiat Oncol Biol Phys
2015
Strong Star Certificate of Appreciation
Sponsor: University o
2015
Outstanding Reviewer of 2014
Sponsor: Int J Radiat Oncol Biol Phys
2013
3rd most downloaded clinical article for 2012
Sponsor: Int J Radiat Oncol Biol Phys
2012
Patient- and Family-Centered Care Award
2011
Hero Fund Recognition/Strong Star Certificate of Appreciation (2 awarded)
Location: University of Rochester Medical Center
2010
Hero Fund/Strong Star Certificate of Appreciation (2 awarded)
Location: University of Rochester Medical Center
2009
Hero Fund Recognition/Strong Star Certificate of Appreciation (8 awarded)
Location: University of Rochester Medical Center
2009
Simon Kramer New Investigator Award
Sponsor: Radiation Therapy Oncology Group (RTOG)
2008
Teacher of the Year Award
Sponsor: Association of Residents in Radiation Oncology (ARRO)
2008
Rubin-Mitchell Teaching Award
Location: University of Rochester
2008
Hero Fund Recognition/Strong Star Certificate of Appreciation (3 awarded)
Location: University of Rochester Medical Center
1999
George V. Metzger Award
Location: University of Rochester
1997
Young Investigator Travel Award
Location: International Workshop on Radiation Damage to DNA
1996 - 1997
Student Travel Awards
Location: Radiation Research Society
1993
The Dean's Research Fellowship
Location: University of Rochester School of Medicine and Dentistry
1993
Academic Commendation
Location: University of Rochester School of Medicine and Dentistry
1992
Outstanding Senior Physics Major Award
Location: University of Notre Dame
1992
Research Scholar
Location: Strong Children's Research Center
1992
Phi Beta Kappa
Sponsor: Epsilon of Indiana Chapter
Location: University of Notre Dame
1991
Alpha Epsilon Delta
Location: University of Notre Dame
1988 - 1992
Honors Program
Location: University of Notre Dame
1988 - 1992
1988 to 1992 National Dean's List (all years)
Location: University of Notre Dame
1988 - 1992
Dean's List (all semesters)
Location: University of Notre Dame
1988
National Honor Society
Location: McQuaid Jesuit High School
1988
Notre Dame Scholar
Location: University of Notre Dame
VIEW ALL expand_more
Clinical Trials
Phase III Trial of Post-Surgical Single Fraction Stereotactic Radiosurgery (SRS) Compared With Fractionated SRS for Resected Metastatic Brain Disease
Lead Researcher: Michael Thomas Milano
This phase III trial studies how well single fraction stereotactic radiosurgery works compared with fractionated stereotactic radiosurgery in treating patients with cancer that has spread to the brain from other parts of the body and has been removed by surgery. Single fraction stereotactic radiosurgery is a specialized radiation therapy that delivers a single, high dose of radiation directly to the tumor and may cause less damage to normal tissue. Fractionated stereotactic radiosurgery delivers multiple, smaller doses of radiation therapy over time. This study may help doctors find out if fractionated stereotactic radiosurgery is better or worse than the usual approach with single fraction stereotactic radiosurgery.
View Study Details
Maintenance Systemic Therapy Versus Consolidative Stereotactic Body Radiation Therapy (SBRT) Plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III Trial
Lead Researcher: Michael Thomas Milano
This randomized phase II/III trial studies how well giving maintenance chemotherapy with or without local consolidation therapy works in treating patients with stage IV non-small cell lung cancer. Drugs used in maintenance chemotherapy, such as docetaxel, pemetrexed disodium, erlotinib hydrochloride, and gemcitabine work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Local consolidation therapy such as radiation/stereotactic body radiation or surgery may kill cancer cells left after initial treatment. Giving maintenance chemotherapy and local consolidation therapy together may work better than maintenance chemotherapy alone in treating patients with stage IV non-small cell lung cancer.
View Study Details
Publications
Journal Articles
6/4/2021
Mihai AM, Armstrong PJ, Hickey D, Milano MT, Dunne M, Healy K, Thirion P, Heron DE, ElBeltagi N, Armstrong JG. "Late Toxicity and Long-Term Local Control in Patients With Ultra-Central Lung Tumours Treated by Intensity-Modulated Radiotherapy-Based Stereotactic Ablative Body Radiotherapy With Homogenous Dose Prescription." Clinical oncology : a journal of the Royal College of Radiologists.. 2021 Jun 4; Epub 2021 Jun 04.
6/1/2021
Chowdhry AK, Milano MT, Soltys SG, Grimm J. "In Regard to Soltys et al." International journal of radiation oncology, biology, physics.. 2021 Jun 1; 110(2):609-611.
5/19/2021
Biswas T, Simone CB, Lo SS, Milano MT. "Defining the role of curative local therapy in oligometastatic cancer: a new era." Annals of palliative medicine.. 2021 May 19; Epub 2021 May 19.
Books & Chapters
2018
Chapter Title: Non-small Cell Lung Cancer Oligometastases (published since 2014)
Book Title: UpToDate
Author List: Milano MT, Vokes EE, West H, Salama JK
Edited By: Rose BD
Published By: UpToDate 2018 in Waltham, MA
2018
Chapter Title: Treatment of Locally Recurrent and Second Primary Head and Neck Cancers (published since 2003)
Book Title: UpToDate
Author List: Milano MT, Chmura SJ, Haraf DJ
Edited By: Rose BD
Published By: UpToDate 2018 in Waltham, MA
2018
Chapter Title: Re-irradiation of Head and Neck Cancer (published since 2008)
Book Title: UpToDate
Author List: Milano MT, Salama JK, Haraf DJ
Edited By: Rose BD
Published By: UpToDate 2018 in Waltham, MA
VIEW ALL PUBLICATIONS